SCHEMBL2616623

SCHEMBL2616623

C/C=C(\CBr)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8719302 1.00
SCHEMBL3888280 1.00
Acetonitrile SCHEMBL27642684 0.89
SCHEMBL15312468 0.83
SCHEMBL15312466 0.83
SCHEMBL7765793 0.79 HCAR2 (0.39)
SCHEMBL9548488 0.79 GRIK1 (0.37)
SCHEMBL8842466 0.79 TSHR (0.41)
SCHEMBL9548489 0.79 GRIK1 (0.37)
SCHEMBL7765784 0.79 HCAR2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114874081-B Preparation method of green efficient alpha-functionalized ketone 中国人民解放军海军军医大学 2023-12-22 CN disclosed
CN-114874081-A Preparation method of green efficient alpha-functionalized ketone 中国人民解放军海军军医大学 2022-08-09 CN disclosed
CN-114031612-A (+/-) -Nicotletrone A and synthesis method of epimer thereof 西北农林科技大学 2022-02-11 CN disclosed
CN-106535862-B Composite material with controlled network structure 义获嘉伟瓦登特公司 2021-04-13 CN disclosed
CN-106659641-B Dental material with peel-on-demand properties 义获嘉伟瓦登特公司 2020-08-07 CN disclosed
US-10342744-B2 Compositions with controlled network structure IVOCLAR VIVADENT AG (LI) 2019-07-09 US disclosed
US-9950067-B2 Trans carotenoids, their synthesis, formulation and uses Diffusion Pharmaceuticals, LLC (US) 2018-04-24 US disclosed
US-20170202798-A1 BIPOLAR TRANS CARTENOID SALTS AND THEIR USES DIFFUSION PHARMACEUTICALS LLC (US) 2017-07-20 US disclosed
US-20170202798-A1 BIPOLAR TRANS CARTENOID SALTS AND THEIR USES DIFFUSION PHARMACEUTICALS LLC (US) 2017-07-20 US disclosed
US-20170172855-A1 Compositions With Controlled Network Structure TECHNISCHE UNIVERSITÄT WIEN (AT) 2017-06-22 US disclosed
US-20070161610-A1 Bipolar trans carotenoid salts and their uses DIFFUSION PHARMACEUTICALS LLC (US) 2007-07-12 US disclosed
US-6818780-B2 APPLICATION IN MEDICINE FOR TREATMENT OF DISORDERS OF IMMUNOLOGICAL SYSTEM CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2004-11-16 US disclosed
EP-1284263-B1 DERIVATIVES OF P- HYDROXY PHENYL PROPIONIC ACID AS ANTIPROLIFERATIVE AGENTS CONSEJO SUPERIOR INVESTIGACION (ES) 2003-12-10 EP disclosed
US-20030199575-A1 P-hydroxyphenyl propionic acid derivatives as antiproliferative agents CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2003-10-23 US disclosed
EP-1284263-A1 DERIVATIVES OF P- HYDROXY PHENYL PROPIONIC ACID AS ANTIPROLIFERATIVE AGENTS CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2003-02-19 EP disclosed
EP-0639566-B1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO LTD (JP) 2001-06-20 EP disclosed
EP-0869943-A1 MONOCYCLIC BETA-LACTAME DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-10-14 EP disclosed
WO-1997021675-A1 MONOCYCLIC BETA-LACTAME DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-06-19 WO disclosed
US-5461158-A Immunodeficiency and autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
EP-0639566-A1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 EP disclosed